Synthesis, biological evaluation and SAR studies of benzimidazole derivatives as H1-antihistamine agents

被引:78
作者
Wang, Xiao Jian [1 ,3 ]
Xi, Mei Yang [2 ]
Fu, Ji Hua [2 ]
Zhang, Fu Rong [1 ,3 ]
Cheng, Gui Fang [1 ,3 ]
Yin, Da Li [1 ,3 ]
You, Qi Dong [2 ]
机构
[1] Peking Union Med Coll, Beijing Key Lab Act Subst Discovery & Drugabil Ev, State Key Lab Bioact Subst & Funct Nat Med, Dept Med Chem,Inst Mat Med, Beijing 100050, Peoples R China
[2] China Pharmaceut Univ, Sch Pharm, Nanjing 210009, Jiangsu, Peoples R China
[3] Chinese Acad Med Sci, Beijing 100050, Peoples R China
关键词
Benzimidazole derivatives; Antihistamine activity; SAR; Anti-PAF activity; hERG; HISTAMINE-RECEPTOR; PHARMACOLOGICAL CHARACTERIZATION; CLONING; EXPRESSION; CHANNELS; CELLS; ANTAGONISTS; ASTEMIZOLE; BINDING;
D O I
10.1016/j.cclet.2012.04.020
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A series of benzimidazole derivatives have been designed, synthesized and evaluated for H-1 antihistamine activity. Six compounds have showed potent antihistamine H-1 activity. The primary SAR analysis indicated that benzyl or benzylidinyl substituted on the exo-nitrogen atom and C2 of the benzimidazole were significant. Further experiments indicated that compound 17d displayed excellent activity to reduce mast cell degranulation, moderate anti-PAF activity and decreased potency on hERG compared to astermizole. Hence compound 17d could serve as anti-allergic agent for further development. (C) 2012 Da Li Yin. Published by Elsevier B.V. on behalf of Chinese Chemical Society. All rights reserved.
引用
收藏
页码:707 / 710
页数:4
相关论文
共 17 条
[1]   SYNTHESIS OF THE SELECTIVE MUSCARINIC AGONIST (3R)-3-(6-CHLOROPYRAZIN-2-YL)-1-AZABICYCLO[2.2.2]OCTANE [J].
ASHWOOD, MS ;
GIBSON, AW ;
HOUGHTON, PG ;
HUMPHREY, GR ;
ROBERTS, DC ;
WRIGHT, SHB .
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 1995, (06) :641-644
[2]   TIME-COURSE OF IGE BINDING TO RAT PERITONEAL-CELLS AFTER SENSITIZATION WITH ALUM-ADSORBED OVALBUMIN AND BORDETELLA-PERTUSSIS [J].
BEHRENDT, H .
INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1987, 82 (3-4) :283-288
[3]   Design, synthesis, and biological evaluation of substituted 2-cyclohexyl-4-phenyl-1H-imidazoles:: Potent and selective neuropeptide Y Y5-receptor antagonists [J].
Blum, CA ;
Zheng, XZ ;
De Lombaert, S .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (09) :2318-2325
[4]  
BORN CVR, 1962, NATURE, V194, P927
[5]   Validation of a [3H]astemizole binding assay in HEK293 cells expressing HERG K+ channels [J].
Chiu, PJS ;
Marcoe, KF ;
Bounds, SE ;
Lin, CH ;
Feng, JJ ;
Lin, A ;
Cheng, FC ;
Crumb, WJ ;
Mitchell, R .
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2004, 95 (03) :311-319
[6]   GENOMIC CLONING, HETEROLOGOUS EXPRESSION AND PHARMACOLOGICAL CHARACTERIZATION OF A HUMAN HISTAMINE H1-RECEPTOR [J].
DEBACKER, MD ;
GOMMEREN, W ;
MOEREELS, H ;
NOBELS, G ;
VANGOMPEL, P ;
LEYSEN, JE ;
LUYTEN, WHML .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 197 (03) :1601-1608
[7]   MOLECULAR-CLONING OF A GENE ENCODING THE HISTAMINE-H2-RECEPTOR [J].
GANTZ, I ;
SCHAFFER, M ;
DELVALLE, J ;
LOGSDON, C ;
CAMPBELL, V ;
UHLER, M ;
YAMADA, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (02) :429-433
[8]  
Hill SJ, 1997, PHARMACOL REV, V49, P253
[9]  
HILL SJ, 1990, PHARMACOL REV, V42, P45
[10]   MOLECULAR PHARMACOLOGICAL ASPECTS OF HISTAMINE-RECEPTORS [J].
LEURS, R ;
SMIT, MJ ;
TIMMERMAN, H .
PHARMACOLOGY & THERAPEUTICS, 1995, 66 (03) :413-463